31 Queen Street, Melbourne, Victoria, 3000, Australia
Biotechnology company transforming treatment of respiratory infections.
Total Raised
$70 M
Rounds
3
Links
Verticals
Series B
Oct 2025
$22M
Equity
Jun 2021
$25M
Series A
Oct 2018
$23M
Christophe Demaison
Co-founder and CEO & Director
